Group One Trading’s Verona Pharma VRNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | – | Sell |
-28,400
| Closed | -$3.03M | – | 9253 |
|
|
2025
Q3 | $3.03M | Sell |
28,400
-170,200
| -86% | -$17.8M | 0.01% | 1927 |
|
|
2025
Q2 | $18.8M | Buy |
198,600
+16,500
| +9% | +$1.22M | 0.04% | 460 |
|
|
2025
Q1 | $11.6M | Buy |
182,100
+136,700
| +301% | +$8.18M | 0.03% | 558 |
|
|
2024
Q4 | $2.11M | Sell |
45,400
-74,100
| -62% | -$2.78M | ﹤0.01% | 1861 |
|
|
2024
Q3 | $3.44M | Buy |
119,500
+52,700
| +79% | +$1.3M | 0.01% | 1296 |
|
|
2024
Q2 | $966K | Buy |
66,800
+56,300
| +536% | +$822K | ﹤0.01% | 2010 |
|
|
2024
Q1 | $169K | Sell |
10,500
-33,200
| -76% | -$574K | ﹤0.01% | 3707 |
|
|
2023
Q4 | $869K | Buy |
43,700
+14,200
| +48% | +$210K | ﹤0.01% | 2588 |
|
|
2023
Q3 | $481K | Buy |
29,500
+15,700
| +114% | +$302K | ﹤0.01% | 2952 |
|
|
2023
Q2 | $292K | Buy |
13,800
+13,600
| +6,800% | +$290K | ﹤0.01% | 3572 |
|
|
2023
Q1 | $4.02K | Sell |
200
-1,900
| -90% | -$41K | ﹤0.01% | 6375 |
|
|
2022
Q4 | $54.9K | Sell |
2,100
-2,000
| -49% | -$26.6K | ﹤0.01% | 4917 |
|
|
2022
Q3 | $42K | Buy |
+4,100
| New | +$34.6K | ﹤0.01% | 5547 |
|
|
2022
Q1 | – | Sell |
-100
| Closed | -$1K | – | 8789 |
|
|
2021
Q4 | $1K | Buy |
+100
| New | +$511 | ﹤0.01% | 8037 |
|
Other funds holding VRNA
Group One Trading's VRNA Position: Q4 2024 in Review
Group One Trading sold out of Verona Pharma (VRNA) in Q4 2024, closing a stake of 49,577 shares — an estimated $1.86M sold.
Group One Trading first reported a position in VRNA in Q4 2021 and held it in 11 quarters. The position peaked at $1.43M in Q3 2024. 191 funds tracked by Wall St. Rank hold VRNA as of Q4 2024.
- Group One Trading reported no remaining Verona Pharma position as of Q4 2024 after selling out during the quarter.
- Group One Trading sold 49,577 Verona Pharma shares in Q4 2024, an estimated $1.86M.
- Group One Trading first reported a position in Verona Pharma in Q4 2021 and held it in 11 quarters.
- Group One Trading's Verona Pharma position peaked at $1.43M in Q3 2024.
- 191 funds tracked by Wall St. Rank held Verona Pharma as of Q4 2024.
Based on Group One Trading's 13F filing for Q4 2024, filed 14 Feb 2025.